R. H. A. Becker

3.7k total citations · 1 hit paper
72 papers, 2.8k citations indexed

About

R. H. A. Becker is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, R. H. A. Becker has authored 72 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 27 papers in Surgery and 14 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in R. H. A. Becker's work include Diabetes Management and Research (28 papers), Diabetes Treatment and Management (25 papers) and Pancreatic function and diabetes (23 papers). R. H. A. Becker is often cited by papers focused on Diabetes Management and Research (28 papers), Diabetes Treatment and Management (25 papers) and Pancreatic function and diabetes (23 papers). R. H. A. Becker collaborates with scholars based in Germany, United States and France. R. H. A. Becker's co-authors include Gabriele Wiemer, Annke Frick, Bernward A. Schölkens, Tim Heise, Wolfgang Linz, Karin Bergmann, Raphael Dahmen, Rudi Busse, Klaus Rave and Anne Lehmann and has published in prestigious journals such as Circulation, Diabetes Care and Kidney International.

In The Last Decade

R. H. A. Becker

68 papers receiving 2.6k citations

Hit Papers

New Insulin Glargine 300 Units·mL−1 Provides a More Even ... 2014 2026 2018 2022 2014 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. New Insulin Glargine 300 Units·mL−1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 Units·mL−1
    2014 292 citations R. H. A. Becker, Tim Heise et al. profile →

Peers

R. H. A. Becker
Ichiro Komiya Japan
Anselm T. Bäumer Germany
T Kuusi Finland
Tomoya Mita Japan
Ryoyu Takeda Japan
Marcus Hompesch United States
Aurélie Nguyen Dinh Cat United Kingdom
Monika Kellerer Germany
Michael Mark Germany
Luke Norton United States
Ichiro Komiya Japan
R. H. A. Becker
Citations per year, relative to R. H. A. Becker R. H. A. Becker (= 1×) peers Ichiro Komiya

Countries citing papers authored by R. H. A. Becker

Since Specialization
Citations

This map shows the geographic impact of R. H. A. Becker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. H. A. Becker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. H. A. Becker more than expected).

Fields of papers citing papers by R. H. A. Becker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. H. A. Becker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. H. A. Becker. The network helps show where R. H. A. Becker may publish in the future.

Co-authorship network of co-authors of R. H. A. Becker

This figure shows the co-authorship network connecting the top 25 collaborators of R. H. A. Becker. A scholar is included among the top collaborators of R. H. A. Becker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. H. A. Becker. R. H. A. Becker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jinnouchi, Hideaki, Masayoshi Koyama, Yoshinori Takahashi, et al.. (2015). Continuous Glucose Monitoring During Basal–Bolus Therapy Using Insulin Glargine 300 U mL−1 and Glargine 100 U mL−1 in Japanese People with Type 1 Diabetes Mellitus: A Crossover Pilot Study. Diabetes Therapy. 6(2). 143–152. 22 indexed citations
2.
Sandow, J., et al.. (2015). Equivalent Recombinant Human Insulin Preparations and their Place in Therapy. touchREVIEWS in Endocrinology. 11(1). 10–10. 21 indexed citations
3.
Lorenz, M., et al.. (2013). Effects of lixisenatide once daily on gastric emptying in type 2 diabetes — Relationship to postprandial glycemia. Regulatory Peptides. 185. 1–8. 122 indexed citations
4.
Entezami, Michael, et al.. (2008). Akute Torsion einer Hydrosalpinx. Ultraschall in der Medizin - European Journal of Ultrasound. 16(1). 33–35.
5.
Becker, R. H. A., Annke Frick, Lenore Teichert, et al.. (2008). Fluctuation and reproducibility of exposure and effect of insulin glargine in healthy subjects*. Diabetes Obesity and Metabolism. 10(11). 1105–1113. 14 indexed citations
6.
Becker, R. H. A.. (2007). Insulin Glulisine Complementing Basal Insulins: A Review of Structure and Activity. Diabetes Technology & Therapeutics. 9(1). 109–121. 59 indexed citations
7.
Gerich, John, et al.. (2006). Fluctuation of Serum Basal Insulin Levels Following Single and Multiple Dosing of Insulin Glargine. Diabetes Technology & Therapeutics. 8(2). 237–243. 34 indexed citations
8.
9.
Rave, Klaus, Leszek Nosek, Lutz Heinemann, et al.. (2004). Dependency of the Metabolic Effect of sc-Injected Human Regular Insulin on Intra-abdominal Fat in Patients with Type 2 Diabetes. Hormone and Metabolic Research. 36(5). 307–311. 4 indexed citations
10.
Becker, R. H. A., et al.. (2003). Langzeitbeobachtung nach einer bilateralen endogenen Klebsiella-Endophthalmitis. Klinische Monatsblätter für Augenheilkunde. 220(5). 357–361. 1 indexed citations
11.
Scholtz, H. E., et al.. (2003). Equipotency of insulin glargine and regular human insulin on glucose disposal in healthy subjects following intravenous infusion. Acta Diabetologica. 40(4). 156–162. 20 indexed citations
12.
Linz, Wolfgang, et al.. (1998). Nephroprotection by long-term ACE inhibition with ramipril in spontaneously hypertensive stroke prone rats. Kidney International. 54(6). 2037–2044. 18 indexed citations
13.
Becker, R. H. A., et al.. (1997). Sustained Diurnal Blood Pressure Reduction in SHR with Ramipril Assessed by Telemetric Monitoring. Clinical and Experimental Hypertension. 19(8). 1233–1246. 4 indexed citations
14.
Heitsch, Holger, R. H. A. Becker, Heinz‐Werner Kleemann, & Adalbert Wagner. (1997). 3N-Methylbiphenylsulfonylurea and -carbamate substituted imidazo[4,5-b]pyridines. Potent antagonists of the ANG II AT1 receptors. Bioorganic & Medicinal Chemistry. 5(4). 673–678. 26 indexed citations
15.
16.
Becker, R. H. A., Wolfgang Linz, & Bernward A. Schölkens. (1989). Pharmacological Interference with the Cardiac Renin-Angiotensin System. Journal of Cardiovascular Pharmacology. 14(4). S10–S15. 16 indexed citations
17.
Wiemer, Gabriele, et al.. (1989). Effects of Hoe 065, a compound structurally related to inhibitors of angiotensin converting enzyme, on acetylcholine metabolism in rat brain. European Journal of Pharmacology. 166(1). 31–39. 12 indexed citations
18.
Becker, R. H. A., Udo Albus, Wolfgang Linz, et al.. (1989). High-Affinity Binding of the Converting Enzyme Inhibitor, Ramiprilat, to Isolated Human Glomeruli. Journal of Cardiovascular Pharmacology. 13. S31–S34. 1 indexed citations
19.
Connolly, Kevin, et al.. (1989). Differential effects of anti-arthritic agents on subnormal plasma iron levels in adjuvant arthritic rats. Inflammation Research. 27(3-4). 328–331. 1 indexed citations
20.
Striessnig, Jörg, Manfred Grabner, Hartmut Glossmann, et al.. (1988). Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166. Naunyn-Schmiedeberg s Archives of Pharmacology. 337(3). 331–40. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ichiro Komiya Breakdown of academic impact, for papers by Anselm T. Bäumer Breakdown of academic impact, for papers by T Kuusi Breakdown of academic impact, for papers by Tomoya Mita Breakdown of academic impact, for papers by Ryoyu Takeda Breakdown of academic impact, for papers by Marcus Hompesch Breakdown of academic impact, for papers by Aurélie Nguyen Dinh Cat Breakdown of academic impact, for papers by Monika Kellerer Breakdown of academic impact, for papers by Michael Mark Breakdown of academic impact, for papers by Luke Norton
Rankless by CCL
2026